Page last updated: 2024-08-22

dideoxyadenosine and cyclosporine

dideoxyadenosine has been researched along with cyclosporine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Cho, CS; Cho, ML; Kim, HY; Kim, WU; Lee, SH; Min, DJ; Min, JK; Min, SY; Park, SH	1

Other Studies

2 other study(ies) available for dideoxyadenosine and cyclosporine

Article	Year
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Cyclosporine differentially regulates interleukin-10, interleukin-15, and tumor necrosis factor a production by rheumatoid synoviocytes. Arthritis and rheumatism, 2002, Volume: 46, Issue:1 Topics: 1-Methyl-3-isobutylxanthine; Antimetabolites; Antirheumatic Agents; Arthritis, Rheumatoid; Bucladesine; Calcineurin Inhibitors; Cells, Cultured; Cyclic AMP; Cyclosporine; Cytokines; Dideoxyadenosine; Fibroblasts; Gene Expression; Humans; Immunosuppressive Agents; Interleukin-10; Interleukin-15; Phosphodiesterase Inhibitors; RNA, Messenger; Synovial Membrane; Tacrolimus; Tumor Necrosis Factor-alpha	2002

Article

Year

In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.

Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023

Cyclosporine differentially regulates interleukin-10, interleukin-15, and tumor necrosis factor a production by rheumatoid synoviocytes.

Arthritis and rheumatism, 2002, Volume: 46, Issue:1

Topics: 1-Methyl-3-isobutylxanthine; Antimetabolites; Antirheumatic Agents; Arthritis, Rheumatoid; Bucladesine; Calcineurin Inhibitors; Cells, Cultured; Cyclic AMP; Cyclosporine; Cytokines; Dideoxyadenosine; Fibroblasts; Gene Expression; Humans; Immunosuppressive Agents; Interleukin-10; Interleukin-15; Phosphodiesterase Inhibitors; RNA, Messenger; Synovial Membrane; Tacrolimus; Tumor Necrosis Factor-alpha

2002